Published in Semin Hematol on April 01, 2011
Translational control in cancer etiology. Cold Spring Harb Perspect Biol (2013) 1.71
Genetics. Mysterious ribosomopathies. Science (2013) 1.44
Quality control mechanisms during ribosome maturation. Trends Cell Biol (2013) 1.22
Gradual processing of the ITS1 from the nucleolus to the cytoplasm during synthesis of the human 18S rRNA. Nucleic Acids Res (2013) 1.11
The inherited bone marrow failure syndromes. Pediatr Clin North Am (2013) 0.97
Impaired ribosomal subunit association in Shwachman-Diamond syndrome. Blood (2012) 0.92
Ribosomopathies: Global process, tissue specific defects. Rare Dis (2015) 0.82
Retention of OsNMD3 in the cytoplasm disturbs protein synthesis efficiency and affects plant development in rice. J Exp Bot (2014) 0.80
Probing the mechanisms underlying human diseases in making ribosomes. Biochem Soc Trans (2016) 0.76
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes. Sci Rep (2016) 0.75
Ribosomopathy-like properties of murine and human cancers. PLoS One (2017) 0.75
Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med (2005) 8.80
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature (2008) 8.38
X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet (1998) 6.82
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature (2010) 5.43
Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet (2002) 4.62
Ribosomopathies: human disorders of ribosome dysfunction. Blood (2010) 4.43
THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION. J Pediatr (1964) 4.12
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med (2009) 4.03
Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet (2008) 4.02
The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer (2004) 3.58
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature (2003) 3.05
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med (2009) 2.89
Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood (2008) 2.68
The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet (2007) 2.58
Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood (2002) 2.50
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients. Proc Natl Acad Sci U S A (2007) 2.39
Depletion of yeast ribosomal proteins L16 or rp59 disrupts ribosome assembly. J Cell Biol (1990) 2.02
Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood (2006) 2.02
The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood (2005) 1.95
The Saccharomyces cerevisiae TIF6 gene encoding translation initiation factor 6 is required for 60S ribosomal subunit biogenesis. Mol Cell Biol (2001) 1.84
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide. Proc Natl Acad Sci U S A (2009) 1.83
Structure and expression of the Saccharomyces cerevisiae CRY1 gene: a highly conserved ribosomal protein gene. Mol Cell Biol (1987) 1.79
The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood (2007) 1.69
The carboxy-terminal extension of yeast ribosomal protein S14 is necessary for maturation of 43S preribosomes. Mol Cell (2004) 1.66
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome. Br J Haematol (2007) 1.64
Advances in the 5q- syndrome. Blood (2010) 1.57
The Shwachman-Bodian-Diamond syndrome protein family is involved in RNA metabolism. J Biol Chem (2005) 1.52
Shwachman-Diamond syndrome. Pediatr Blood Cancer (2005) 1.32
Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am (2009) 1.31
Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest (2008) 1.29
Loss of the mouse ortholog of the shwachman-diamond syndrome gene (Sbds) results in early embryonic lethality. Mol Cell Biol (2006) 1.29
Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential. Blood (2007) 1.25
Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21
Immune function in patients with Shwachman-Diamond syndrome. Br J Haematol (2001) 1.21
Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses. Hum Mol Genet (2009) 1.02
The 5q- syndrome. Scand J Haematol Suppl (1986) 1.00
Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol (2005) 0.99
The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies. Br J Haematol (2009) 0.99
Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation. Clin Genet (2011) 0.99
Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br J Haematol (2009) 0.96
Phylogeny, sequence conservation, and functional complementation of the SBDS protein family. Genomics (2006) 0.96
The Shwachman-Bodian-Diamond syndrome associated protein interacts with HsNip7 and its down-regulation affects gene expression at the transcriptional and translational levels. Exp Cell Res (2007) 0.95
Congenital disorders of ribosome biogenesis and bone marrow failure. Biol Blood Marrow Transplant (2009) 0.95
Distinct ribosome maturation defects in yeast models of Diamond-Blackfan anemia and Shwachman-Diamond syndrome. Haematologica (2009) 0.95
Conformational flexibility and molecular interactions of an archaeal homologue of the Shwachman-Bodian-Diamond syndrome protein. BMC Struct Biol (2009) 0.94
SBDS expression and localization at the mitotic spindle in human myeloid progenitors. PLoS One (2009) 0.92
Sdo1p, the yeast orthologue of Shwachman-Bodian-Diamond syndrome protein, binds RNA and interacts with nuclear rRNA-processing factors. Yeast (2009) 0.90
Does isochromosome 7q mandate bone marrow transplant in children with Shwachman-Diamond syndrome? Br J Haematol (2002) 0.89
Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. Blood Cells Mol Dis (2008) 0.81
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol (2008) 4.41
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99
The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood (2005) 1.95
Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood (2010) 1.88
Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J Clin Invest (2007) 1.80
The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood (2007) 1.69
Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1. Stem Cells (2010) 1.60
Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood (2003) 1.49
Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci (2011) 1.33
Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am (2009) 1.31
Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest (2008) 1.29
Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood (2004) 1.18
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol (2010) 1.17
The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis (2002) 1.16
Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell (2013) 1.10
Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update. Hematol Oncol Clin North Am (2012) 1.09
Ribosomal dysfunction and inherited marrow failure. Br J Haematol (2008) 1.08
H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep (2013) 1.01
Congenital disorders of ribosome biogenesis and bone marrow failure. Biol Blood Marrow Transplant (2009) 0.95
Distinct ribosome maturation defects in yeast models of Diamond-Blackfan anemia and Shwachman-Diamond syndrome. Haematologica (2009) 0.95
Impaired ribosomal subunit association in Shwachman-Diamond syndrome. Blood (2012) 0.92
Clinical spectrum and molecular pathophysiology of Shwachman-Diamond syndrome. Curr Opin Hematol (2011) 0.90
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer (2013) 0.88
Ectopic human mesenchymal stem cell-coated scaffolds in NOD/SCID mice: an in vivo model of the leukemia niche. Tissue Eng Part C Methods (2010) 0.87
Centrosome amplification and aneuploidy in bone marrow failure patients. Genes Chromosomes Cancer (2004) 0.86
The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol (2015) 0.86
Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes. Pediatr Blood Cancer (2004) 0.85
Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome. Blood (2013) 0.84
Impaired growth, hematopoietic colony formation, and ribosome maturation in human cells depleted of Shwachman-Diamond syndrome protein SBDS. Pediatr Blood Cancer (2012) 0.82
Breast cancer in a case of Shwachman Diamond syndrome. Pediatr Blood Cancer (2011) 0.82
SBDS protein expression patterns in the bone marrow. Pediatr Blood Cancer (2010) 0.82
Fanconi anemia protein complex is a novel target of the IKK signalsome. J Cell Biochem (2002) 0.82
Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. Blood Cells Mol Dis (2008) 0.81
Mitochondrial function is impaired in yeast and human cellular models of Shwachman Diamond syndrome. Biochem Biophys Res Commun (2013) 0.81
Subtyping of Fanconi anemia patients: implications for clinical management. Blood (2003) 0.81
FAM111B Mutation Is Associated With Inherited Exocrine Pancreatic Dysfunction. Pancreas (2016) 0.80
Antibody-dependent cell cytotoxicity to breast cancer targets despite inhibitory KIR signaling. Anticancer Res (2006) 0.80
Genomic instability in bone marrow failure syndromes. Am J Hematol (2004) 0.80
Common variable immunodeficiency as the initial presentation of dyskeratosis congenita. J Allergy Clin Immunol (2013) 0.79
Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene. Am J Med Genet A (2011) 0.79
Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis. Mol Med (2008) 0.78
Analysis of baseline and cisplatin-inducible gene expression in Fanconi anemia cells using oligonucleotide-based microarrays. BMC Blood Disord (2002) 0.78
A simulation-based comparison of two methods for determining relaxation rates from relaxometry images. Magn Reson Imaging (2011) 0.77
Leukemia fusion proteins and co-repressor complexes: changing paradigms. J Cell Biochem (2005) 0.77
Phosphorylation of Fanconi anemia protein, FANCA, is regulated by Akt kinase. Biochem Biophys Res Commun (2002) 0.76
Spindle microtubule dysfunction and cancer predisposition. J Cell Physiol (2014) 0.76
Marrow failure. Hematology Am Soc Hematol Educ Program (2002) 0.76
Diamond Blackfan Anemia: A Nonclassical Patient With Diagnosis Assisted by Genomic Analysis. J Pediatr Hematol Oncol (2016) 0.75
Genetic and transcriptional analysis of spindle checkpoint genes in bone marrow failure patients. Blood Cells Mol Dis (2003) 0.75
Domains involved in ETO and human N-CoR interaction and ETO transcription repression. Leuk Res (2004) 0.75
Expression of the Shwachman-Bodian-Diamond syndrome (SBDS) protein in human pancreatic cancer and chronic pancreatitis. Histol Histopathol (2008) 0.75